牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

海特生物（300683）

4.5

综合诊断：4.5分打败了43%的股票！

卖出
减持
中性
增持
买入

短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
中期趋势：
正处于反弹阶段。
长期趋势：
已有41家主力机构披露2025-12-31报告期持股数据，持仓量总计4963.47万股，占流通A股40.66%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

5.5分

3.1分

5.5分

3.7分

4.2分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：5.5技术面打败了70%的股票技术面评分前10的股票

近期的平均成本为24.24元。空头行情中，目前正处于反弹阶段，投资者可适当关注。

技术面得分最高的股票

平均成本

近期的平均成本为24.24元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"24.24","date":1782705570,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势跑输大盘，跑输行业平均水平。

[{"date":"2026.06.29","stock":"6.47","trade":"6.11","ind":"0.19"},{"date":"2026.06.26","stock":"-4.07","trade":"-2.39","ind":"-3.44"},{"date":"2026.06.25","stock":"-0.94","trade":"-0.87","ind":"1.82"},{"date":"2026.06.24","stock":"-2.00","trade":"0.51","ind":"1.24"},{"date":"2026.06.23","stock":"5.30","trade":"2.39","ind":"-3.17"},{"date":"2026.06.22","stock":"-1.78","trade":"0.66","ind":"2.13"},{"date":"2026.06.18","stock":"0.17","trade":"1.96","ind":"0.94"},{"date":"2026.06.17","stock":"-3.05","trade":"-0.41","ind":"1.31"},{"date":"2026.06.16","stock":"0.77","trade":"-0.42","ind":"0.93"},{"date":"2026.06.15","stock":"-0.88","trade":"-0.52","ind":"3.79"},{"date":"2026.06.12","stock":"2.80","trade":"2.48","ind":"0.75"},{"date":"2026.06.11","stock":"-1.34","trade":"-1.51","ind":"-0.68"},{"date":"2026.06.10","stock":"-1.12","trade":"-0.40","ind":"-2.06"},{"date":"2026.06.09","stock":"-0.20","trade":"1.04","ind":"3.02"},{"date":"2026.06.08","stock":"-3.56","trade":"-3.31","ind":"-3.22"},{"date":"2026.06.05","stock":"-1.22","trade":"-0.44","ind":"-2.21"},{"date":"2026.06.04","stock":"-1.84","trade":"-1.37","ind":"-0.27"},{"date":"2026.06.03","stock":"2.10","trade":"-1.00","ind":"0.73"},{"date":"2026.06.02","stock":"-5.05","trade":"-1.85","ind":"1.63"},{"date":"2026.06.01","stock":"0.07","trade":"-0.06","ind":"-1.51"},{"date":"2026.05.29","stock":"-2.14","trade":"-1.55","ind":"-1.81"}]

海特生物,深证成指,医疗服务指数

压力支撑

该股压力位为23.46元，支撑位为22.14元。

[{"text":"\u538b\u529b\u4f4d","value":"23.46","date":1782662400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"22.14","date":1782662400,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.1资金面打败了46%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

医疗服务行业，近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。

更新时间：06月30日 12:51

机构今日流向(万元)	3561.36	机构5日流向(万元)	1135.26
机构10日流向(万元)	2388.69	机构20日流向(万元)	-2838.77

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量增加534.15万股，其中基金净减仓2家，主力净增仓22家，请投资者中长期谨慎为宜。

截止2025-12-31，共41家主力机构（基金35家，一般法人3家，QFII3家），持仓量总计4963.47万股，占流通A股40.66%
其中，基金持仓与2025-06-30相比：
增仓：1家，增持 0.18万股
减仓：3家，减持 2.01万股
新出现在主力名单中：34家，持有650.03万股
从主力名单中消失：12家，原持有114.05万股

消息面诊股

诊断结果：5.5消息面打败了35%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	募资投向		2026-06-05
一般消息	高管变动	因个人工作变动	2026-05-12
一般消息	股东大会	年度股东大会	2026-04-24
一般消息	分红转增	不分配不转增	2026-04-24
一般消息	重大事项	公司股东股份解押	2026-03-23
一般消息	募资投向	公司购买资产	2026-03-19
一般消息	高管变动	因个人原因	2026-02-05
重大利空	业绩预告	预计增亏	2026-01-23
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-12-31
一般消息	高管变动	取消监事会	2025-11-07
一般消息	分红转增	不分配不转增	2025-08-26

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	1条	1条	0条

行业面诊股

诊断结果：3.7行业面打败了59%的股票医疗服务行业最新资金流向

近10日来该行业走势明显向上，接近大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势明显向上，接近大盘。

[{"date":"2026.06.29","price":"0.19","value":"6.11"},{"date":"2026.06.26","price":"-3.44","value":"-2.39"},{"date":"2026.06.25","price":"1.82","value":"-0.87"},{"date":"2026.06.24","price":"1.24","value":"0.51"},{"date":"2026.06.23","price":"-3.17","value":"2.39"},{"date":"2026.06.22","price":"2.13","value":"0.66"},{"date":"2026.06.18","price":"0.94","value":"1.96"},{"date":"2026.06.17","price":"1.31","value":"-0.41"},{"date":"2026.06.16","price":"0.93","value":"-0.42"},{"date":"2026.06.15","price":"3.79","value":"-0.52"},{"date":"2026.06.12","price":"0.75","value":"2.48"},{"date":"2026.06.11","price":"-0.68","value":"-1.51"},{"date":"2026.06.10","price":"-2.06","value":"-0.40"},{"date":"2026.06.09","price":"3.02","value":"1.04"},{"date":"2026.06.08","price":"-3.22","value":"-3.31"},{"date":"2026.06.05","price":"-2.21","value":"-0.44"},{"date":"2026.06.04","price":"-0.27","value":"-1.37"},{"date":"2026.06.03","price":"0.73","value":"-1.00"},{"date":"2026.06.02","price":"1.63","value":"-1.85"},{"date":"2026.06.01","price":"-1.51","value":"-0.06"},{"date":"2026.05.29","price":"-1.81","value":"-1.55"}]

深证成指,医疗服务行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	凯莱英	44.46%	34.73%	6.1分
2	皓元医药	32.17%	13.95%	6.8分
3	美迪西	29.69%	21.14%	6.7分
4	药康生物	25.42%	23.61%	6.3分
5	泰格医药	24.61%	19.32%	6.5分
6	药明康德	24.18%	18.10%	6.9分
7	博腾股份	18.72%	22.63%	6.2分
8	康龙化成	14.74%	21.67%	6.7分
9	诚达药业	14.07%	5.57%	5.2分
10	睿智医药	13.07%	29.40%	5.7分
11	迪安诊断	12.77%	1.24%	5.3分
12	昭衍新药	12.60%	7.99%	6.5分
13	益诺思	12.51%	13.28%	6.7分
14	华康洁净	12.24%	16.10%	6.2分
15	成都先导	11.29%	14.59%	6.7分
16	泓博医药	9.56%	10.09%	5.9分
17	毕得医药	9.22%	17.20%	5.9分
18	九洲药业	8.29%	5.19%	5.9分
19	普蕊斯	7.56%	13.78%	5.0分
20	万邦医药	6.84%	15.63%	4.7分
21	诺思格	3.80%	7.38%	5.4分
22	药石科技	3.34%	7.20%	5.7分
23	金凯生科	2.77%	8.12%	4.8分
24	阳光诺和	2.27%	7.71%	6.0分
25	百奥赛图	0.88%	18.17%	7.5分
26	南模生物	0.37%	11.58%	5.3分
27	-	-0.66%	-3.05%	分
28	华大基因	-2.42%	-1.86%	4.8分
29	奥浦迈	-4.61%	8.67%	5.8分
30	和元生物	-5.68%	1.48%	4.8分
31	爱尔眼科	-5.70%	1.30%	5.5分
32	国际医学	-6.35%	-1.24%	5.4分
33	通策医疗	-6.36%	-0.40%	5.6分
34	百花医药	-7.53%	-1.17%	4.6分
35	何氏眼科	-9.06%	-3.50%	4.5分
36	博济医药	-9.64%	4.05%	5.3分
37	海特生物	-9.67%	4.41%	4.5分
38	美年健康	-10.02%	-8.08%	5.2分
39	百诚医药	-10.08%	9.46%	5.2分
40	诺禾致源	-10.28%	0.56%	5.4分
41	ST中珠	-10.36%	-0.44%	4.4分
42	创新医疗	-10.76%	0.71%	4.7分
43	金域医学	-11.09%	-7.55%	4.3分
44	华厦眼科	-11.41%	-4.72%	4.7分
45	盈康生命	-11.92%	-0.58%	5.3分
46	兰卫医学	-12.11%	-2.66%	4.8分
47	大东方	-12.15%	-4.22%	4.8分
48	光正眼科	-12.27%	-3.17%	5.0分
49	澳洋健康	-13.25%	-4.32%	5.0分
50	贝瑞基因	-13.38%	-3.54%	4.8分
51	三博脑科	-15.83%	-7.86%	4.1分
52	皓宸医疗	-16.60%	-6.64%	4.8分
53	新里程	-18.43%	-6.35%	4.8分
54	普瑞眼科	-19.46%	-5.98%	5.0分
55	大湖股份	-19.96%	-6.37%	4.9分
56	南华生物	-23.29%	-6.32%	5.3分

<上一页 1 2 3 4 5...10 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：4.2基本面打败了2%的股票连续3年业绩增长30%的公司

该公司运营状况不佳，暂时未获得多数机构的显著认同，长期投资价值一般。

个股深一度

潜在高分红能力：弱（27.5分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 46/102 ， 24/102。

[{"date":"2026-03-31","value":"-1.07","vol":"0.96"},{"date":"2025-12-31","value":"-10.16","vol":"2.21"},{"date":"2025-09-30","value":"-6.84","vol":"3.24"},{"date":"2025-06-30","value":"-1.65","vol":"2.24"},{"date":"2025-03-31","value":"-0.58","vol":"0.88"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	-1.07	-10.16	-6.84	-1.65	-0.58
行业(%)	0.96	2.21	3.24	2.24	0.88

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"38.47","vol":"34.16"},{"date":"2025-12-31","value":"42.64","vol":"34.36"},{"date":"2025-09-30","value":"41.81","vol":"36.06"},{"date":"2025-06-30","value":"40.74","vol":"36.21"},{"date":"2025-03-31","value":"44.38","vol":"35.05"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	38.47	42.64	41.81	40.74	44.38
行业(%)	34.16	34.36	36.06	36.21	35.05

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 33/102 ， 47/102。

[{"date":"2026-03-31","value":"1.52","vol":"16.75"},{"date":"2025-12-31","value":"-16.57","vol":"8.22"},{"date":"2025-09-30","value":"-6.45","vol":"3.06"},{"date":"2025-06-30","value":"-3.36","vol":"2.87"},{"date":"2025-03-31","value":"18.79","vol":"-0.73"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	1.52	-16.57	-6.45	-3.36	18.79
行业(%)	16.75	8.22	3.06	2.87	-0.73

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"-65.44","vol":"79.49"},{"date":"2025-12-31","value":"-233.48","vol":"23.26"},{"date":"2025-09-30","value":"-297.78","vol":"20.05"},{"date":"2025-06-30","value":"-72.10","vol":"-63.31"},{"date":"2025-03-31","value":"15.81","vol":"-22.07"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	-65.44	-233.48	-297.78	-72.10	15.81
行业(%)	79.49	23.26	20.05	-63.31	-22.07

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 48/102 ， 28/102。

[{"date":"2026-03-31","value":"0.06","vol":"0.10"},{"date":"2025-12-31","value":"0.20","vol":"0.44"},{"date":"2025-09-30","value":"0.15","vol":"0.32"},{"date":"2025-06-30","value":"0.10","vol":"0.21"},{"date":"2025-03-31","value":"0.05","vol":"0.10"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.06	0.20	0.15	0.10	0.05
行业(次)	0.10	0.44	0.32	0.21	0.10

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.21","vol":"3.44"},{"date":"2025-12-31","value":"3.24","vol":"15.84"},{"date":"2025-09-30","value":"2.53","vol":"10.95"},{"date":"2025-06-30","value":"1.57","vol":"7.15"},{"date":"2025-03-31","value":"0.80","vol":"3.62"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	1.21	3.24	2.53	1.57	0.80
行业(次)	3.44	15.84	10.95	7.15	3.62

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"-1.58","vol":"0.86"},{"date":"2025-12-31","value":"-0.42","vol":"20.95"},{"date":"2025-09-30","value":"-12.24","vol":"16.52"},{"date":"2025-06-30","value":"-6.99","vol":"16.38"},{"date":"2025-03-31","value":"-31.78","vol":"-0.79"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	-1.58	-0.42	-12.24	-6.99	-31.78
行业	0.86	20.95	16.52	16.38	-0.79

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.51","vol":"0.89"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.63","vol":"0.91"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.51	-	0.63	-
行业	0.00	0.89	0.01	0.91	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 44/102 ， 38/102。

[{"date":"2026-03-31","value":"4.17","vol":"3.37"},{"date":"2025-12-31","value":"3.98","vol":"3.64"},{"date":"2025-09-30","value":"4.60","vol":"3.67"},{"date":"2025-06-30","value":"4.89","vol":"3.57"},{"date":"2025-03-31","value":"4.76","vol":"3.68"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	4.17	3.98	4.60	4.89	4.76
行业	3.37	3.64	3.67	3.57	3.68

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"2.58","vol":"2.78"},{"date":"2025-12-31","value":"3.63","vol":"3.00"},{"date":"2025-09-30","value":"4.11","vol":"2.94"},{"date":"2025-06-30","value":"4.35","vol":"2.87"},{"date":"2025-03-31","value":"4.21","vol":"2.97"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	2.58	3.63	4.11	4.35	4.21
行业	2.78	3.00	2.94	2.87	2.97

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 43/102 ， 46/102。

[{"date":"2026-03-31","value":"15.68","vol":"32.97"},{"date":"2025-12-31","value":"15.80","vol":"32.98"},{"date":"2025-09-30","value":"14.91","vol":"32.60"},{"date":"2025-06-30","value":"14.71","vol":"33.58"},{"date":"2025-03-31","value":"15.03","vol":"32.05"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	15.68	15.80	14.91	14.71	15.03
行业(%)	32.97	32.98	32.60	33.58	32.05

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.19","vol":"0.97"},{"date":"2025-12-31","value":"0.19","vol":"0.97"},{"date":"2025-09-30","value":"0.18","vol":"0.92"},{"date":"2025-06-30","value":"0.17","vol":"0.96"},{"date":"2025-03-31","value":"0.18","vol":"0.96"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.19	0.19	0.18	0.17	0.18
行业(%)	0.97	0.97	0.92	0.96	0.96

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"-0.14","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-1.21","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.69","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-2.31","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[海特生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]